| Net Cash Provided by (Used in) Operating Activities |
-527,219,000 |
USD |
+44.5% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
393,715,000 |
USD |
-56.3% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares, Issued |
182,204,000 |
shares |
+48.9% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-134,742,000 |
USD |
-1.7% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
471,299,000 |
USD |
+10.9% |
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
40,307,000 |
USD |
+2.6% |
Q4 2024 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
45,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Current Income Tax Expense (Benefit) |
131,000 |
USD |
|
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
4,291,097,000 |
USD |
+48.5% |
Q2 2025 |
Q3 2025 |
| Interest Expense |
165,487,000 |
USD |
+97.4% |
Q2 2025 |
Q3 2025 |